Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | INSM | INSMED INC | Healthcare | 3,049.0 | $531K | 0.46% | NEW | — | $174.04 | -38.9% |
| 42 | LEGN | LEGEND BIOTECH CORP | Healthcare | 24,397.0 | $530K | 0.46% | NEW | — | $21.74 | +7.0% |
| 43 | ARGX | ARGENX SE | Healthcare | 630.0 | $530K | 0.46% | NEW | — | $840.95 | +7.9% |
| 44 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 3,734.0 | $530K | 0.46% | NEW | — | $141.83 | +21.7% |
| 45 | NUVL | NUVALENT INC | Healthcare | 5,261.0 | $529K | 0.46% | NEW | — | $100.59 | +23.2% |
| 46 | INCY | INCYTE CORP | Healthcare | 5,350.0 | $528K | 0.46% | NEW | — | $98.77 | +18.3% |
| 47 | CYTK | CYTOKINETICS INC | Healthcare | 8,313.0 | $528K | 0.46% | NEW | — | $63.54 | +29.2% |
| 48 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 16,967.0 | $528K | 0.46% | NEW | — | $31.12 | -38.3% |
| 49 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 19,766.0 | $528K | 0.46% | NEW | — | $26.71 | -6.8% |
| 50 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 31,040.0 | $528K | 0.46% | NEW | — | $17.00 | -66.5% |
| 51 | STOK | STOKE THERAPEUTICS INC | Healthcare | 16,621.0 | $528K | 0.46% | NEW | — | $31.74 | -9.4% |
| 52 | — | APOGEE THERAPEUTICS INC | — | 6,984.0 | $527K | 0.46% | NEW | — | $75.48 | — |
| 53 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 11,316.0 | $527K | 0.46% | NEW | — | $46.55 | +79.8% |
| 54 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 1,080.0 | $526K | 0.46% | NEW | — | $487.25 | +8.6% |
| 55 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 12,672.0 | $525K | 0.46% | NEW | — | $41.43 | -32.0% |
| 56 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 12,725.0 | $524K | 0.46% | NEW | — | $41.21 | +155.7% |
| 57 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 31,762.0 | $524K | 0.46% | NEW | — | $16.51 | +40.2% |
| 58 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 1,318.0 | $524K | 0.46% | NEW | — | $397.65 | -33.4% |
| 59 | EXEL | EXELIXIS INC | Healthcare | 11,948.0 | $524K | 0.46% | NEW | — | $43.83 | +27.1% |
| 60 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 11,678.0 | $523K | 0.46% | NEW | — | $44.82 | +46.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%